LivaNova PLC (NASDAQ:LIVN; LSE: LIVN) (“LivaNova” or the “Company”), a market-leading medical technology and innovation company, today recognizes that more than one million people in the United States with drug-resistant epilepsy continue to be treated unsuccessfully with drugs, despite the proven effectiveness of non-drug treatment options. LivaNova’s VNS Therapy®, for example, is a medical device treatment specifically designed for people with drug-resistant epilepsy that is already used by more than 85,000 people around the world.
One in three people with epilepsy has the type that is not well controlled with drugs, called drug-resistant epilepsy. For those people, prescribing more medicine is usually not the most effective option. In fact, research shows that if you haven’t found seizure freedom after your first two drugs, there is a 95 percent chance that no drug or combination of drugs will result in seizure freedom.
“Despite what we know about drug-resistant epilepsy, the majority of people affected by this condition will continue to be prescribed additional medications instead of being evaluated for surgery or seen in a specialized epilepsy facility,” said Jason Richey, president of LivaNova’s U.S. Region and general manager of the Neuromodulation Business Franchise. “This treatment gap means over one million individuals in the U.S. with undertreated epilepsy remain at risk for dangerous side effects of continued seizures, including injury, depression, memory issues and death.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7966451-livanova-vns-therapy-epilepsy/
Announced today by VICHY Laboratoires, the VICHY EXPOSOME GRANT will promote and encourage research activity on the skin exposome. One research grant of 15 000 € will be awarded annually to a research project proposal in the field of exposome and skin.
What is exposome?
The human body is subjected to and responds to complex exposures throughout the lifespan, including exposures from the environment, diet, lifestyle. For this highly complex interaction, the term exposome was recently coined by Dr. Christopher Wild at the World Health Organization‘s International Agency for Research on Cancer.
The exposome analysis, therefore, complements the human genome by providing a comprehensive description of individuals’ lifelong environmental exposures. Exposome research aims to look at the holistic view of the human body’s exposures, how the body responds to those exposures, and their combined effects.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7751451-vichy-announces-exposome-grant/
The Bonnie J. Addario Lung Cancer Foundation invites you to join The Living Room, a lively and interactive online support group for those who are directly and indirectly affected by lung cancer. The April Living Room will feature a patient-focused program, titled “Sharing My Personal Journey.” There’s no guest speaker this month, just stories and experiences from patients and family who can offer hope to others.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56176-bjalcf-the-living-room-online-support-group-sharing-my-personal-journey
LONDON, 23 Jan., 2019 – Dell Technologies (NYSE:DELL) announces new additions to its portfolio of purpose-built technology designed to challenge, engage and inspire K-12 educators and students worldwide. This newest line of products, including an interactive monitor plus intelligently tough Latitude and Dell Chromebook devices and a new charging cart, helps educators integrate technology with new teaching and learning practices, while encouraging students to follow their own path of discovery.
“Recent Dell Technologies research on Generation Z – those born in the mid-1990s and later – confirms our belief that for students to be successful now and in the future, educators must empower them to drive their own success and support them with tools and resources that ignite students’ natural curiosities,” said Adam Garry, director of education strategy at Dell. “These new devices enable both educators and students to inquire, create and collaborate seamlessly, wherever learning takes place.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8356753-dell-technologies-bett-education/
The summer season is coming to an end, but that doesn't mean there isn't some time for you to get a little summer sun. If you're planning a last minute road trip, it's important to plan ahead, research restaurants and hotels and make sure to perform the proper maintenance on your car. And, through the end of August, the Super 8 hotel brand is holding an exciting sweepstakes that will help add some miles to any road trip.
Try exeml.com to find all the latest feeds. I found some on Hillary Clintons Laugh. Just some fun. News, blogs, video, photos and a whole lot more. Keep up to date with current events or do research for your blog. Thousands of uses. Try exeml.com Now.
The focus of the research was to analyse and compare late invoice payments of different countries and make contextual points. Also, the highlighted statistical figures represent global commercial transactions. In total, around 38 countries were analysed and compared for late invoice payments.
Visit: https://brodmin.com/invoicing/late-invoice-statistics/
New research from Carfax suggests that millions of people may be driving, buying, or selling potentially dangerous cars due to an unfixed recall. The company’s annual research on the issue shows more than 46 million cars nationwide have at least one safety recall that’s never been fixed. In fact, five million of them were bought and sold by potentially unsuspecting consumers in 2014.
One of the most alarming discoveries is that people driving or buying family-oriented vehicles – specifically minivans and SUVs – are most at risk. One in three minivans and one in five SUVs has an unfixed recall, according to Carfax.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7385551-carfax-unfixed-recall-data/
Lancôme is unveiling Genes Day on October 22, a one day fundraiser in support of St. Jude Children’s Research Hospital.
In celebration of the beauty of scientific research, Lancôme will donate $7 from each bottle of their latest skin care breakthrough, Génifique Youth Activating Concentrate, sold that day to St. Jude Children’s Research Hospital to support the research and treatment at St. Jude.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/lancome/46646/
Pioneers in sun research for over 40 years, Lancaster ushers in a new era in sun protection with a discovery that has been integrated into its brand new Sun Beauty line: Infrared Technology. A bold, avant-garde step towards enjoying the sun without the least bit of guilt by using the most complete sun protection offered by Lancaster.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53804-lancastersuncare-infraredtechnology
Lamma Dragon Boat Race, The toughest race on the calendar 40 Men’s, Women’s and Mixed teams compete over the full international 500-metre length course in the \
Automobili Lamborghini S.p.A. and Callaway Golf Company (NYSE: ELY) have signed an agreement to connect the resources of their world-renowned Research and Development teams. This unique alliance establishes an ongoing collaboration to develop innovative technologies and materials designed to enhance the performance of each company’s products. The partnership, as well as the introduction of a new, co-developed material called Forged Composite™, was officially celebrated today at the 2010 Paris Motor Show by Automobili Lamborghini President and CEO Stephan Winkelmann and George Fellows, President and CEO, Callaway Golf.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/callawaygolf/40580/
